Substance use disorder: Epidemiology, medical consequences and treatment.

Trastorno por uso de sustancias: epidemiología, complicaciones médicas y tratamiento.
Alcohol Benzodiacepinas Benzodiazepines Cannabis Cocaine Cocaína Complicaciones médicas Epidemiology Epidemiología Medical consequences Opiates Opiáceos Substance use disorder Trastorno por uso de sustancias Tratamiento Treatment

Journal

Medicina clinica
ISSN: 1578-8989
Titre abrégé: Med Clin (Barc)
Pays: Spain
ID NLM: 0376377

Informations de publication

Date de publication:
12 Jan 2024
Historique:
received: 26 08 2023
revised: 07 11 2023
accepted: 08 11 2023
medline: 14 1 2024
pubmed: 14 1 2024
entrez: 13 1 2024
Statut: aheadofprint

Résumé

Substance use is a common health problem, and substance use disorder, which is its most severe presentation, is associated with multiple medical consequences and a negative impact on individual and on population health. Substance use disorder needs to be addressed as any chronic medical condition; therefore, it has to be detected at the early stages and has to be properly treated to prevent drug-related harm. Internists should be able to recognize and treat intoxication and abstinence. Internists should also be able to refer the patient to state of the art long term treatment, aimed to detoxification and treatment induction to promote abstinence and prevent relapse. In this narrative review we will discuss substance use epidemiology, its main medical consequences and its treatment, with a focus on alcohol, opiates, cocaine and other stimulants, cannabis and benzodiazepines.

Identifiants

pubmed: 38218656
pii: S0025-7753(23)00750-9
doi: 10.1016/j.medcli.2023.11.016
pii:
doi:

Types de publication

Journal Article Review

Langues

eng spa

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2023 Elsevier España, S.L.U. All rights reserved.

Auteurs

Daniel Fuster (D)

Unidad de Adicciones, Servicio de Medicina Interna, Hospital Universitari Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Barcelona, España. Electronic address: dfuster.germanstrias@gencat.cat.

Paola Zuluaga (P)

Unidad de Adicciones, Servicio de Medicina Interna, Hospital Universitari Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Barcelona, España.

Robert Muga (R)

Unidad de Adicciones, Servicio de Medicina Interna, Hospital Universitari Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Barcelona, España.

Classifications MeSH